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Abstract
Background: Blood stream infections (BSI) are life-threatening infections in intensive care units
(ICU), and prognosis is highly dependent on early detection. Procalcitonin levels have been shown
to accurately and quickly distinguish between BSI and noninfectious inflammatory states in critically
ill patients. It is, however, unknown to what extent a recent history of sepsis (namely, secondary
sepsis) can affect diagnosis of BSI using PCT.
Methods: review of the medical records of every patient with BSI in whom PCT dosage at the
onset of sepsis was available between 1st September, 2006 and 31st July, 2007.
Results: 179 episodes of either primary (n = 117) or secondary (n = 62) sepsis were included.
Procalcitonin levels were found to be markedly lower in patients with secondary sepsis than in
those without (6.4 [9.5] vs. 55.6 [99.0] ng/mL, respectively; p < 0.001), whereas the SOFA score
was similar in the two groups. Although patients in the former group were more likely to have
received steroids and effective antibiotic therapy prior to the BSI episode, and despite a higher
proportion of candidemia in this group, a low PCT value was found to be independently associated
with secondary sepsis (Odd Ratio = 0.33, 95% Confidence Interval: 0.16–0.70; p  = 0.004).
Additional patients with suspected but unconfirmed sepsis were used as controls (n = 23). Thus,
diagnostic accuracy of PCT as assessed by the area under the receiver-operating characteristic
curves (AUROCC) measurement was decreased in the patients with secondary sepsis compared
to those without (AUROCC = 0.805, 95% CI: 0.699–0.879, vs. 0.934, 95% CI: 0.881–0.970,
respectively; p < 0.050).
Conclusion: In a critically ill patient with BSI, PCT elevation and diagnosis accuracy could be lower
if sepsis is secondary than in those with a first episode of infection.
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Background
When the different causes of intensive care units (ICU)-
acquired infections are considered, blood stream infec-
tion (BSI) is of particular interest given the reported high
rates of associated mortality [1]. Early recognition of such
episodes is therefore critical in order to improve outcome
in critically ill patients with positive blood cultures [2].
Besides clinical signs and symptoms, other markers that
warn the physician about the risk of current systemic
infection are required. Among the available biomarkers,
serum procalcitonin (PCT) has been described as one of
the most promising predictors of bacterial sepsis, espe-
cially in the setting of bacteremia [3-6]. Moreover, it has
been shown that the degree of PCT elevation was closely
related to the degree of organ dysfunction and the out-
come in such patients [7-9]. However, it is worth noting
that the usefulness of PCT for the diagnosis of sepsis is still
a controversial issue as illustrated by a recently published
meta-analysis [10]. Actually, the diagnosis accuracy of
PCT could vary according to the source of infection and
the patient type (i.e., medical vs. surgical) [11,12]. How-
ever, it is not clear whether the time between admission to
the ICU and the onset of sepsis influences PCT behavior.
Obviously, the studies which provide the best predictive
values have included almost exclusively patients with sep-
sis on admittance [7,13]. Such findings are in contrast
with those obtained from studies including a larger
number of patients with ICU-acquired infections [8,14].
Such patients might be different from the former since
they have been exposed to numerous factors likely to
influence PCT release, including a previous history of sep-
sis.
Accordingly, it has been demonstrated in critically ill
patients that sepsis was followed by deep alterations in
the systemic immune response [15-17]. The peripheral
blood monocytes of such patients have been shown to
release smaller amounts of inflammatory mediators, espe-
cially Tumor Necrosis Factor-α (TNF-α), if exposed to
lipopolysaccharide (LPS) in in vitro stimulation [18]. This
so-called "immune paralysis", could account for an
increased risk of secondary infection. Since TNF-α is one
of the main determinants of PCT production in response
to microbial challenge, we hypothesized that the pattern
of PCT elevation was different in critically ill patients who
experienced secondary sepsis compared to those in whom
it was the first episode of infection.
Every BSI episode and its main characteristics are prospec-
tively recorded in our ICU. Since PCT dosage is also usu-
ally performed in every patient with suspected sepsis, this
issue was addressed through a retrospective cohort study.
Methods
Review of medical charts
Each medical chart was reviewed by a member of the med-
ical staff (AS), unaware of the purpose of the study, fol-
lowing a normalized recording sheet.
Definitions
One episode of BSI was defined as the recovery of any bac-
terial or fungal species, in one or more blood cultures.
Patients with Staphylococcus non-aureus bacteremia were
not eligible except if at least 2 consecutive samples grew
for the same species harboring the same antibiotic resist-
ance pattern.
The onset of sepsis was defined as the time when the first
positive blood culture was drawn. Blood samples were
obtained by blood punctures before being processed
using the BACTEC system based both on standard aerobic
and anaerobic media coupled with the 9240 automate
(Beckton Dickinson Diagnostic Instrument System, Para-
mus, NJ, USA). Bacteria and fungi identification was
based on standard methods. The onset of BSI was defined
as the day when the first positive blood culture was
obtained. Two distinct episodes of BSI were considered in
one patient if at least 6 days had elapsed between the 2
sets of positive blood cultures, provided appropriate ther-
apy was implemented and significant clinical improve-
ment was obtained between the two episodes. This time-
interval was chosen since previously published data indi-
cate that blood culture negativation is obtained in a
median time of around 2 days in patients with BSI receiv-
ing appropriate antimicrobial treatment.
Sepsis was considered secondary if a proven infection has
been documented within a 30-day period prior to the cur-
rent episode, regardless of its severity, provided the first
episode had resolved (i.e., resolution of the clinical symp-
toms and evidence of clearance of the causative patho-
gen). Otherwise, sepsis was considered as primary.
Study population
At least one PCT dosage is routinely performed in our ICU
in every patient with systemic inflammatory response syn-
drome (SIRS), as defined by the American College of
Chest Physicians/Society of Critical Care Medicine Con-
sensus Conference, before antimicrobial treatment is
started.
Patients admitted to our 15-bed medical ICU between 1st
September, 2004 and 31st July, 2007 were eligible if at
least one episode of BSI had occurred. The main patient
data including the type of admission (admission was con-
sidered surgical in patients who had undergone surgery
within the 30 days preceding the onset of BSI, and medi-
cal otherwise), clinical status at the onset of BSI (i.e., sep-BMC Infectious Diseases 2008, 8:163 http://www.biomedcentral.com/1471-2334/8/163
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sis, severe sepsis or septic shock), the biological findings
(including PCT, C-Reactive Protein [CRP] and White
Blood Cell [WBC] count), organ dysfunction expressed by
the Sepsis-related Organ Failure Assessment (SOFA) score,
antibiotics received within the 48 hours preceding the BSI
episode, the pathogen(s) involved as well as the infection
source if known, were prospectively collected. Treatment
with steroids within the 7 days preceding the onset of the
sepsis was also taken into account. This was considered
significant if the patient had received at least 2 days of
treatment with 1 mg/kg or more during the 7 days.
Only patients with at least one PCT dosage obtained
within a 12-hour window surrounding the time when the
first positive blood culture was drawn were included in
the study population. The BSI episodes were then divided
into 2 groups according to the kind of sepsis (i.e., second-
ary or primary).
Another population was analyzed over the last 10 months
of the study period (from 1st September, 2006 to 31st July,
2007). Thus, patients undergoing mechanical ventilation
for more than 2 days with clinical suspicion of ventilator-
associated pneumonia (VAP) as defined by the presence
of at least 2 of the following criteria: fever > 38.2°C or
hypothermia < 36.5°C, new purulent tracheal aspirates,
new lung infiltrate on the chest X-ray, unexplained deteri-
oration in gas exchange, were prospectively enrolled in an
observational study that aimed to evaluate the effects of
implementing local guidelines for the diagnosis and the
management of VAP. This study was approved by the
Local Ethic Committee. Notably, PCT dosage was per-
formed in all of these patients at the onset of VAP symp-
toms as part of the study protocol. Only patients in whom
the diagnosis of VAP was considered unlikely (i.e., those
with a clinical pulmonary infection score less than 5,
regardless of the PCT level), in the absence of another
source of infection, were kept for the present study since
they constituted a control group of patients with uncon-
firmed sepsis.
Measurement of PCT level
The Kryptor® immunoassay was used according to the
manufacturer's instructions (Brahms, Hennigsdorf, Ger-
many). The functional sensitivity of the assay is 0.06 ng/
mL. Patients in whom PCT was not measured within the
12 hours following the blood sampling were excluded
from further analysis because of the risk of false-negative
result.
Statistical analysis
Values are expressed as mean ± SD unless otherwise
stated. Continuous variables were compared with the
Mann Whitney U test. Categorical variables were com-
pared using the Chi2-test. We then examined the inde-
pendent contribution of factors that were associated with
the "secondary sepsis" criteria in univariate analysis.
Because of the non-parametric distribution of the varia-
bles of interest, a robust variance estimation was per-
formed prior to logistical regression [19]. In addition,
conformity with the linear gradient of each continuous
variable was checked. If the linear model did not corre-
spond to the variations, the variable was transformed
according to the parsimonious rule. As a result, the
log10PCT was considered instead of the PCT. The candi-
date variables were then manually entered into a logistical
regression model if the associated regression coefficient
had a p value less than 0.20 in univariate analysis, and
then removed if a p value less than 0.05 was obtained by
multivariate analysis. The appropriateness of the model
was eventually tested.
The diagnosis accuracy of serum PCT levels for the early
diagnosis of BSI was then expressed as the area under the
corresponding receiver operating characteristic curve
(AUROCC) and compared for the two groups (i.e., pri-
mary and secondary sepsis) using the values obtained in
the control group.
A p value < 0.05 was considered as statistically significant
for all analyses. The STATA software was used for all anal-
yses (STATA Statistical Package, College Station, Tex.,
USA).
Results
Study population characteristics
Over the 35-month study period, 199 BSI episodes in 194
patients admitted to our ICU were recorded. Among these
episodes, 20 were excluded because of the lack of availa-
ble PCT measurement at the onset of BSI (not done in
time, n = 19; done in time but delayed analysis of the sam-
ple, n = 1). As a result, 179 BSIs episodes in 161 patients
were retained for final analysis. Main baseline characteris-
tics of the patients with BSI are presented in Table 1. It is
worth noting that no difference was found regarding age,
gender, type of admission (i.e., medical or surgical) and
SAPS II. Among these episodes, 117 were considered pri-
mary sepsis as defined previously, whereas the 62 remain-
ing cases were secondary sepsis. The baseline
characteristics of all these patients were found to be com-
parable (Table 1).
In the patients with secondary sepsis, the diagnosis of the
first infection episode was made during a previous hospi-
talization or within the same ICU stay. The median time
elapsed between this first episode and the secondary sep-
sis was 12.5 day (range: 3–30 day). Septic shock was
present in 58.1% of the cases. The main identified bacte-
rial agents were E. coli (17.7%), S. aureus (16.1%), and P.BMC Infectious Diseases 2008, 8:163 http://www.biomedcentral.com/1471-2334/8/163
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aeruginosa (12.9%). Bacteremia was present in 45.2% of
the cases.
Finally, mortality in the ICU was higher in patients with
secondary sepsis than in those without, but the difference
did not reach statistical significance.
As detailed previously, 23 patients in whom the clinical
suspicion of VAP remained unconfirmed, with no evi-
dence of another source of infection, were chosen as neg-
ative controls (i.e., patients with infection signs but
without sepsis). These patients were not found to be dif-
ferent from those with BSI regarding age, gender, SAPS II
and time elapsed from ICU admission to sepsis suspicion
(data not shown). However, the SOFA score was more ele-
vated in the patients with BSI than in those without
proven sepsis (7.0 [4.0] vs. 5.3 [3.1], respectively; p <
0.05).
Bloodstream infections
The main characteristics of the included BSI episodes are
detailed in Table 2. As expected, secondary sepsis occurred
later during the ICU stay than did primary sepsis, and it
was more likely to be nosocomial and acquired in the
ICU. Exposure to antibiotic therapy that had proved effec-
tive in vitro against the causative pathogen and to steroids
was also more frequent in patients with secondary sepsis.
Other differences were noted regarding the causative path-
ogen and the infection source. BSI occurring as secondary
sepsis were more likely to be caused by gram positive bac-
teria and Candida spp than were primary sepsis BSI. In
addition, while pneumonia was the most common infec-
tion source in both groups, urinary tract infections were
significantly less frequent in patients with secondary sep-
sis than in those without. With regard to the severity of the
sepsis, it is worth noting that no difference was found
between the two groups in terms of SOFA scores or in the
proportion of septic shock. However, although the differ-
ence does not reach statistical significance, creatininemia
was considerably higher and the platelet count lower in
patients with primary sepsis than in those with secondary
sepsis BSI.
Serum PCT, CRP and WBC measurements
Serum procalcitonin was significantly lower in patients
with secondary sepsis than in those without (6.4 [9.5] vs.
55.6 [99.0] ng/mL, respectively; p < 0.001) (Figure 1). The
difference was markedly less pronounced for CRP (128.2
[83.1] vs. 188.3 [129.6] mg/L; p = 0.002), while white
blood cell count was comparable (14305 [6885] vs.
14376 [9209] cell/mm3; p = 0.958).
Since secondary infections were more likely to be ICU-
acquired, we hypothesized that blood samples used to
determine PCT levels were obtained earlier during the
course of sepsis than were those in the case of primary sep-
sis. The time between the onset of sepsis and the sampling
for PCT dosage was therefore measured. Although the
median time in the two groups was comparable, PCT was
obtained significantly earlier in the patients with primary
sepsis than in those with secondary sepsis (Table 2).
The variables found to be associated with secondary sepsis
in univariate analysis were entered into a multivariate
analysis model (Table 3, top). Thus, a lower level of PCT
was found to be independently associated with secondary
sepsis (Odd Ratio = 0.33, 95% CI: 0.16–0.70; p = 0.004),
as was the time from ICU admission, candidemia and the
exposure to effective antibiotic therapy prior to BSI. Given
the fact that PCT elevation is thought to be lower in the
patients with candidemia than in those with bacteremia,
a second multivariate analysis model was built excluding
the former episodes of BSI. The same independent predic-
tors of secondary sepsis were identified as in the previous
model (Table 3, bottom).
Table 1: Baseline characteristics and outcome of the patients with blood stream infection according to the sepsis type (i.e. primary or 
secondary sepsis).
Mean (SD) or number (%) Primary sepsis n = 117 Secondary sepsis n = 62 p
Age (year-old) 64.9 (14.9) 65.8 (14.0) 0.690
Female/Male 49 (41.9)/68 (58.1) 25 (40.3)/37 (59.7) 0.966
Medical/surgical admission 104 (88.9)/13 (11.1) 49 (79.0)/13 (21.0) 0.119
SAPS II 47.9 (19.3) 49.1 (18.6) 0.673
ICU mortality 34.2% 46.8% 0.137
SAPS: Simplified Acute Physiologic Score; ICU: Intensive Care Unit.BMC Infectious Diseases 2008, 8:163 http://www.biomedcentral.com/1471-2334/8/163
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Accuracy of PCT as a diagnostic tool
Given the markedly lower magnitude of PCT elevation in
the context of secondary sepsis than in patients with pri-
mary sepsis, we sought to compare its value as a diagnos-
tic tool in the two situations. The abovementioned
population of patients with SIRS and unconfirmed suspi-
cion of VAP was used as control and the corresponding
ROC curves were constructed.
Hence, we found that the accuracy of PCT in the diagnosis
of BSI in patients with secondary sepsis, as assessed
through the area under the ROC curve (AUROCC) calcu-
lation, was not as good as in those with primary sepsis
(0.934, 95% CI: 0.881–0.970; vs. 0.805, 95% CI: 0.699–
0.879, respectively; p < 0.050) (Figure 2).
Finally, we sought to determine the best PCT cut-off val-
ues to differentiate between SIRS and sepsis in our two
groups of patients. Obviously, reliable identification of
patients with secondary sepsis required lower values than
in those with primary sepsis (Table 4). Thus, the sensitiv-
ity of PCT reached 83.8% in the patients with primary sep-
sis if the 2.0 ng/mL threshold was applied, whereas it did
not exceed 58% in those with secondary sepsis. As a result,
the negative predictive value was found to be markedly
lower in these latter patients, even if the 0.25 ng/mL
threshold value was used.
Table 2: Description of the blood stream infection episodes at the time of the first positive blood culture drawing according to the 
sepsis type (i.e. primary or secondary sepsis).
Mean (SD) or number (%) Primary sepsis n = 117 Secondary sepsis n = 62 p
Time elapsed from ICU admission (N. of days) 2.0 (2.4) 15.6 (16.9) < 0.0001
SOFA score 6.9 (4.1) 7.2 (3.9) 0.706
Platelet count (cell/mm3) 185,459 (118,375) 235,935 (183,485) 0.028
Creatininemia (μmol/L) 198.7 (168.5) 163.2 (129.2) 0.149
Prothrombin time (%) 58.8 (21.9) 62.8 (19.9) 0.248
Septic shock 60 (51.7) 31 (50.0) 0.302
Nosocomial sepsis ICU acquired sepsis 34 (35.8) 31 (26.5) 62 (100) 52 (83.9) < 0.0001 < 0.0001
Infection source 0.002
Lung 30 (25.6) 12 (19.3) 0.447
Abdominal 23 (19.7) 18 (29.0) 0.217
Soft tissues 13 (11.1) 4 (6.4) 0.456
Urinary tract 24 (20.5) 2 (3.2) 0.004
Miscellaneous 9 (7.7) 5 (8.1) 0.480
Unknown 18 (15.4) 21 (33.9) 0.008
Involved pathogen bacteria 113 (95.6) 41 (64.4) < 0.0001
Gram positive 51 (43.6) 20 (32.2)
Gram negative 62 (53.0) 21 (33.9)
fungi
Candida spp 4 (3.4) 21 (33.9)
Previous exposure to antibiotic therapy with in vitro activity against the 
involved pathogen
16 (13.7) 21 (33.9) 0.003
Previous exposure to steroids 9 (7.7) 23 (37.1) < 0.0001
Time elapsed between bacteremia onset and PCT sampling (N. of minutes)
Mean (SD) -169.7 (382.6) 6.3 (455.4) 0.011
Median [range] -13.0 [-1072–720] 0.0 [-720–720]
ICU: Intensive Care Unit; SOFA: Sepsis-related Organ Failure Assessment.BMC Infectious Diseases 2008, 8:163 http://www.biomedcentral.com/1471-2334/8/163
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Serum procalcitonin (PCT) level (Fig. A), white blood cells count (WBC) (Fig. B) and C-reactive protein (CRP) level (Fig. C), at  the onset of blood stream infection according to its primary (left boxes, n = 127) or secondary status (right boxes, n = 62) in crit- ically ill patients with clinical sepsis Figure 1
Serum procalcitonin (PCT) level (Fig. A), white blood cells count (WBC) (Fig. B) and C-reactive protein (CRP) 
level (Fig. C), at the onset of blood stream infection according to its primary (left boxes, n = 127) or secondary 
status (right boxes, n = 62) in critically ill patients with clinical sepsis. Data are presented as box plots with median 
lines, 25- and 75-percentile boxes, and 10- and 90-percentile error bars. The circles represent the outliers. A log scale is used 
for the Y-axis in Fig. A. * indicate p < 0.05 between primary and secondary sepsis.
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Discussion
We show here that PCT elevation at the onset of sepsis is
lower in patients with secondary sepsis-related BSI than in
those experiencing their first episode of systemic infec-
tion, regardless of the severity of the disease. In addition,
the accuracy of PCT in the diagnosis of BSI could be
decreased in this subset of critically ill patients, especially
if the negative predictive value of the test was considered.
Such findings could account for the apparent lack of reli-
ability of PCT for the diagnosis of ICU-acquired sepsis
[20,21].
Since PCT elevation reflects the inflammatory cytokine
response to one bacterial insult, such a difference could be
explained by the so-called immune paralysis paradigm.
We cannot, however, draw any definite conclusions
regarding this point since cytokine levels were not meas-
ured simultaneously with PCT. Further prospective stud-
ies are therefore needed to test this hypothesis.
Another explanation is the fact that in our study, second-
ary sepsis was more likely to be caused by gram positive
bacteria and Candida  species than was primary sepsis.
Actually, we have shown previously, like others, that PCT
elevation could be lower when these pathogens are iso-
lated from blood cultures as compared to gram negative
bacteria [22-24]. In addition, a low PCT elevation was still
found as an independent predictor of secondary sepsis
after having excluded from the analysis the patients with
candidemia.
The medication given to patients prior to sepsis could also
account for differences in PCT elevation. Since patients in
the secondary sepsis group spent more time in the ICU
than did those without, one could expect that they were
more likely to have received steroids and antibiotics prior
to the septic episode we analyzed. We did in fact find that
larger amounts of steroids had been given to them. Simi-
larly, patients with secondary sepsis were more likely to
have received at least one antibiotic agent active against
the causative bacteria prior to sepsis. Taken together, these
data suggest that the inflammatory response as reflected
by PCT elevation might have been blunted by steroids
and/or appropriate antibiotics. However, although cumu-
lative evidence has emphasized the anti-inflammatory
impact of steroids in critically ill patients, there is little
clinical evidence of a possible relationship with PCT ele-
vation during sepsis [25-28]. The impact of prior treat-
ment with antibiotics is also debatable. According to in
vitro observations, bactericidal antibiotic therapy should
accentuate the inflammatory response rather than blunt it
through the liberation of microbial products that are
known to trigger the release of PCT [29]. As a result, our
findings provide putative but questionable explanations
regarding the differences between secondary and primary
sepsis in terms of PCT elevation.
Several limitations of our study must be mentioned.
Because of the retrospective design, putative confounding
variables cannot be excluded. PCT dosing may not have
been performed within the same time frame in both
groups. In accordance with this possibility, but surpris-
ingly, the mean time between the onset of sepsis and the
taking of blood samples for PCT analysis was longer in
patients with secondary sepsis than in those without. We
should therefore consider this difference as a conservative
bias since higher values should therefore have been
expected in the secondary sepsis group. In addition, simi-
lar results in terms of PCT elevation were obtained when
only patients with ICU-acquired sepsis were considered
(data not shown). Finally, one cannot exclude the possi-
bility that despite comparable SAPS II on admission and
SOFA scores patients with primary sepsis were sicker than
those with secondary sepsis since higher levels of creat-
ininemia and lower platelet counts were reported. This
finding as well as renal impairment per se could account
for greater PCT elevation in these patients [8,30]. In addi-
tion, it is known that a longer ICU stay is associated with
a worse nutritional status, which could in turn lead to a
lower PCT release, although evidence is still lacking [31].
However, the fact that mortality was lower in patients
with primary sepsis makes this hypothesis unlikely. The
choice of our control group could also raise several con-
cerns. Hence, it is worth noting that the SOFA score was
Table 3: Multivariate analysis of the factors associated with secondary sepsis in critically ill patients with blood stream infection.
Odd ratio Variable type 95% CI p
Time elapsed from ICU admission 1.38 continuous 1.23 1.54 < 0.001
Log10PCT 0.33 continuous 0.16 0.70 0.004
Candidemia (Yes) 7.02 dichotomous 1.48 33.2 0.014
Previous exposure to antibiotic therapy with in vitro activity against the involved pathogen (Yes) 4.28 dichotomous 1.31 13.95 0.016
ICU: Intensive Care Unit; PCT: Procalcitonin; CI: Confidence Interval.BMC Infectious Diseases 2008, 8:163 http://www.biomedcentral.com/1471-2334/8/163
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Receiver operating characteristic (ROC) curve of serum procalcitonin (PCT) for the diagnosis of blood stream infection in crit- ically ill patients with either primary (Fig. A), or secondary (Fig. B) sepsis Figure 2
Receiver operating characteristic (ROC) curve of serum procalcitonin (PCT) for the diagnosis of blood stream 
infection in critically ill patients with either primary (Fig. A), or secondary (Fig. B) sepsis. Plain circles indicate PCT 
values. Area under the ROC curve = 0.934, 95% CI: 0.881–0.970; vs. 0.805, 95% CI: 0.699–0.879, respectively; p < 0.050.
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lower in this group than in the patients with proven sepsis
(i.e., BSI). This could have led to an overestimation of the
diagnosis accuracy of PCT in differentiating between sep-
sis and non-infectious inflammatory states. This was how-
ever not the objective of our study. In addition, one could
also argue that patients from the control group might have
met S.I.R.S. criteria several days before VAP suspicion.
This could account for an immunodepression state and in
turn, for lower PCT values [32]. Any way, such limitations
do not influence the comparison between the patients
with secondary sepsis to those without.
Conclusion
Despite the possible shortcomings, we have shown that
PCT might be less reliable for the diagnosis of sepsis in
critically ill patients with secondary sepsis than in those
with a first episode of BSI. Since milder PCT elevation is
expected in the former patients, it may be advisable to use
lower cut-off values in the setting of secondary sepsis. In
addition, our findings emphasize the impact of factors
such as time from ICU admission or previous exposure to
an effective antibiotic therapy on PCT elevation. These
should be therefore taken in account in any study that
aims to determine the accuracy of PCT in the diagnosis of
BSI in critically ill patients.
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